Molecular magnetic resonance imaging of liver inflammation using an oxidatively activated probe

Asrani, 2019, Burden of liver diseases in the world, J Hepatol, 70, 151, 10.1016/j.jhep.2018.09.014 Koyama, 2017, Liver inflammation and fibrosis, J Clin Invest, 127, 55, 10.1172/JCI88881 Del Campo, 2018, Role of inflammatory response in liver diseases: therapeutic strategies, World J Hepatol, 10, 1, 10.4254/wjh.v10.i1.1 Ros, 2018, Imaging of diffuse and inflammatory liver disease, 237 Jayakumar, 2016, Noninvasive markers of fibrosis and inflammation in nonalcoholic fatty liver disease, Curr Hepatol Rep, 15, 86, 10.1007/s11901-016-0296-8 Neuwelt, 2015, Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation, Am J Roentgenol, 204, W302, 10.2214/AJR.14.12733 Li, 2008, Pharmacokinetics and biodistribution of nanoparticles, Mol Pharmaceutics, 5, 496, 10.1021/mp800049w Reimer, 2003, Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications, Eur Radiol, 13, 1266, 10.1007/s00330-002-1721-7 Keramida, 2014, Accumulation of (18)F-FDG in the liver in hepatic steatosis, Am J Roentgenol, 203, 643, 10.2214/AJR.13.12147 Jiang, 2014, NADPH oxidases in chronic liver diseases, Adv Hepatol, 2014, 10.1155/2014/742931 Wang, 2019, Molecular magnetic resonance imaging using a redox-active iron complex, J Am Chem Soc, 141, 5916, 10.1021/jacs.9b00603 Percie du Sert, 2020, Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0, Plos Biol, 18 Matsumoto, 2013, An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis, Int J Exp Pathol, 94, 93, 10.1111/iep.12008 Reeder, 2004, Multicoil Dixon chemical species separation with an iterative least-squares estimation method, Magn Reson Med, 51, 35, 10.1002/mrm.10675 Yu, 2008, Multiecho water-fat separation and simultaneous R2∗ estimation with multifrequency fat spectrum modeling, Magn Reson Med, 60, 1122, 10.1002/mrm.21737 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Zhou, 2021, Positron emission tomography-magnetic resonance imaging pharmacokinetics, in vivo biodistribution, and whole-body elimination of Mn-PyC3A, Invest Radiol, 56, 261, 10.1097/RLI.0000000000000736 Erstad, 2019, Tumor contrast enhancement and whole-body elimination of the manganese-based magnetic resonance imaging contrast agent Mn-PyC3A, Invest Radiol, 54, 697, 10.1097/RLI.0000000000000593 Gale, 2018, A manganese-based alternative to gadolinium: contrast enhanced MR angiography, pharmacokinetics, and metabolism, Radiology, 286, 865, 10.1148/radiol.2017170977 Gale, 2015, A manganese alternative to gadolinium for MRI contrast, J Am Chem Soc, 137, 15548, 10.1021/jacs.5b10748 2019, EASL clinical practice guidelines: drug-induced liver injury, J Hepatol, 70, 1222, 10.1016/j.jhep.2019.02.014 Roth, 2013, Drug-induced liver disease, 157 David, 2010, Drug-induced liver injury, US Gastroenterol Hepatol Rev, 6, 73 Knodell, 1981, Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis, Hepatology, 1, 431, 10.1002/hep.1840010511 Bedossa, 1996, An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group, Hepatology, 24, 289, 10.1002/hep.510240201 Ishak, 1995, Histological grading and staging of chronic hepatitis, J Hepatol, 22, 696, 10.1016/0168-8278(95)80226-6 Hennes, 2008, Simplified criteria for the diagnosis of autoimmune hepatitis, Hepatology, 48, 169, 10.1002/hep.22322 Balitzer, 2017, Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria, Mod Pathol, 30, 773, 10.1038/modpathol.2016.267 Sanyal, 2011, Endpoints and clinical trial design for nonalcoholic steatohepatitis, Hepatology, 54, 344, 10.1002/hep.24376 Elphick, 2007, Spectrum of liver histology in presumed decompensated alcoholic liver disease, Am J Gastroenterol, 102, 780, 10.1111/j.1572-0241.2006.01034.x Lackner, 2021, Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease, J Hepatol, 75, 810, 10.1016/j.jhep.2021.05.029 Portmann, 2012, Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation, Histopathology, 60, 236, 10.1111/j.1365-2559.2011.03853.x de Vries, 2017, Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: an international cohort study, Hepatology, 65, 907, 10.1002/hep.28963 Argo, 2009, Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis, J Hepatol, 51, 371, 10.1016/j.jhep.2009.03.019 Sarin, 2016, Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update, Hepatol Int, 10, 1, 10.1007/s12072-015-9675-4 2017, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, J Hepatol, 67, 370, 10.1016/j.jhep.2017.03.021 Hoppmann, 2020, Drug-induced liver injury in the setting of chronic liver disease, Clin Liver Dis, 24, 89, 10.1016/j.cld.2019.09.006 Younossi, 2018, Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis, Hepatology, 68, 349, 10.1002/hep.29721 Imajo, 2016, Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography, Gastroenterology, 150, 626, 10.1053/j.gastro.2015.11.048 Bastati, 2020, Does the functional liver imaging score derived from gadoxetic acid-enhanced MRI predict outcomes in chronic liver disease?, Radiology, 294, 98, 10.1148/radiol.2019190734 Allen, 2020, The role of three-dimensional magnetic resonance elastography in the diagnosis of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery, Hepatology, 71, 510, 10.1002/hep.30483 Allen, 2020, Multiparametric magnetic resonance elastography improves the detection of NASH regression following bariatric surgery, Hepatol Commun, 4, 185, 10.1002/hep4.1446 Asanuma, 2010, Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease, Gut, 59, 258, 10.1136/gut.2009.176651 Smits, 2016, Noninvasive differentiation between hepatic steatosis and steatohepatitis with MR imaging enhanced with USPIOs in patients with nonalcoholic fatty liver disease: a proof-of-concept study, Radiology, 278, 782, 10.1148/radiol.2015150952 Pulli, 2017, Molecular MR imaging of myeloperoxidase distinguishes steatosis from steatohepatitis in nonalcoholic fatty liver disease, Radiology, 284, 390, 10.1148/radiol.2017160588 Atanasova, 2020, Molecular magnetic resonance imaging of fibrin deposition in the liver as an indicator of tissue injury and inflammation, Invest Radiol, 55, 209, 10.1097/RLI.0000000000000631 Forman, 2002, Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling, Am J Respir Crit Care Med, 166, S4, 10.1164/rccm.2206007 Marckmann, 2006, Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging, J Am Soc Nephrol, 17, 2359, 10.1681/ASN.2006060601 Kanda, 2015, Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy, Radiology, 276, 228, 10.1148/radiol.2015142690 McDonald, 2022, Symptoms associated with gadolinium exposure (SAGE): a suggested term, Radiology, 302, 270, 10.1148/radiol.2021211349 Ramachandran, 2017, Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology, J Clin Transl Res, 3, 157 Pirasteh, 2016, Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging, Abdom Radiol (NY), 41, 1744, 10.1007/s00261-016-0736-5